Market Wire – Cannasat Therapeutics Reports Results for the Year Ended December 31, 2009
March 5, 2010 — Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a specialty clinical development pharmaceutical company targeting CNS diseases, today announced its…
More: continued here
Filed under Acne Treatments by on Mar 7th, 2010.
Leave a Comment